Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 06, 2022

SELL
$53.86 - $66.8 $10,772 - $13,360
-200 Reduced 1.57%
12,515 $674,000
Q2 2022

Jul 20, 2022

BUY
$63.83 - $80.0 $811,598 - $1.02 Million
12,715 New
12,715 $817,000
Q3 2019

Nov 04, 2019

SELL
$81.4 - $89.78 $516,890 - $570,103
-6,350 Closed
0 $0
Q2 2019

Jul 09, 2019

BUY
$73.44 - $82.41 $466,344 - $523,303
6,350 New
6,350 $520,000
Q1 2019

Apr 03, 2019

SELL
$64.48 - $81.31 $1.08 Million - $1.36 Million
-16,750 Closed
0 $0
Q4 2018

Jan 11, 2019

BUY
$61.45 - $77.8 $1.03 Million - $1.3 Million
16,750 New
16,750 $1.1 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.